Rahway, New Jersey Tuesday, October 28, 2025, 12:00 Hrs [IST] ...
WINREVAIR is the subject of a licensing agreement with Bristol Myers Squibb.
Q3 2025 Earnings Call Transcript October 27, 2025 BioMarin Pharmaceutical Inc. misses on earnings expectations. Reported EPS ...
The Argus on MSN
New exercise group for people with neurological conditions
A new exercise group is launching to support people with neurological conditions. Active Hastings has received a £2,940 grant from Parkinson’s UK to launch the Exercise Group for Neurological ...
The Pensacola News Journal is working with high schools in Escambia and Santa Rosa County to put their top students in the ...
Experts continue to debate whether the health status benefits are real and enough to justify doing the procedures for severe ...
His ability to throw an early interception and come right back and take his team right down the field was impressive,” Tony ...
3don MSNOpinion
Democrats in the wilderness
After the 2024 defeat, the Democratic Party is struggling to find its voice, torn between progressivism, populism and a ...
The progression-free survival (PFS) hazard ratio (HR) was 0.60 (p < 0.0001) for ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy. The median PFS was 11.14 months in the ivonescimab ...
Novartis AG ( NYSE: NVS) M&A Call October 27, 2025 8:00 AM EDT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback